Saturday, 20 April 2024
Diffusion Pharmaceuticals Inc.
-
Overlay
-
Indicators
-
Settings
-
Period
04:11 | 24/2/18
Alpha Beta Stock
Asian stocks advanced Friday after Wall Street rebounded from a two-day losing streak and Japanese inflation edged higher. KEEPING SCORE: The Shanghai Composite Index gained 0.3 percent to 3,279.74 and Tokyo's Nikkei 225 advanced 0.4 percent to 21,814 ...
more»
02:52 | 24/2/18
StockNewsGazette
The shares of bluebird bio, Inc. have increased by more than 12.97% this year alone. The shares recently went down by -2.99% or -$6.2 and now trades at $201.20.
more»
06:22 | 23/2/18
Business Daily
Shares of Diffusion Pharmaceuticals Inc (DFFN) are moving on volatility today 1.58% or 0.01 from the open. The NASDAQ listed company saw a recent bid of 0.65 and 827817 shares have traded hands in the session.
more»
04:11 | 23/2/18
Alpha Beta Stock
Wall Street stocks tumbled into negative territory on Wednesday (Feb 21) after the minutes of the last Federal Reserve meeting revived concerns about higher interest rates.
more»
02:30 | 17/2/18
NASDAQ Times
The focus on performance of the Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) that has shown a discernible change in trend levels over the path of recent market activity.
more»
03:52 | 14/2/18
Alpha Beta Stock
Day traders strive to make money by exploiting minute price movements in individual assets (usually stocks, though currencies, futures, and options are traded as well), usually leveraging large amounts of capital to do so, therefore they trade on ...
more»
10:00 | 7/2/18
GlobeNewswire
CHARLOTTESVILLE, Va., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of cancer patients, today announced ...
more»
07:33 | 3/2/18
Simply Wall St
Leading Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) as the CEO, David Kalergis took the company to a valuation of $9.34M. Understanding how CEOs are incentivised to run and grow their company is an important aspect of investing in a stock.
more»
02:07 | 2/2/18
GlobeNewswire
Diffusion Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on improving patient outcomes in unmet medical needs using its novel small molecule trans sodium crocetinate (TSC).
more»
10:00 | 30/1/18
GlobeNewswire
CHARLOTTESVILLE, Va., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of cancer patients, today announced ...
more»